申请人:The Upjohn Company
公开号:US04593096A1
公开(公告)日:1986-06-03
A process for treating hypertension comprising the systemic administering to a hypertensive subject or a novel compound of the formula: ##STR1## wherein X is alkyl of from 1 to 3 carbon atoms, inclusive, or alkenyl of from 3 to 5 carbon atoms, inclusive. R.sub.1 is --NH.sub.2. R.sub.2 is chloro, bromo, or iodo. R.sub.3 is hydrogen or fluorine. R.sub.4 is hydrogen or fluorine, and R.sub.5 is hydrogen, fluorine, or CH.sub.3 ; or salt thereof, in association with a pharmaceutical carrier. The amount administered is from 0.1 mg to 400 mg/kg of body weight, dosage unit form and dosage amounts disclosed.
一种治疗高血压的方法,包括将化合物按照以下公式系统地注射给高血压患者:##STR1## 其中,X是1至3个碳原子的烷基,包括或者3至5个碳原子的烯基。R.sub.1是--NH.sub.2。R.sub.2是氯、溴或碘。R.sub.3是氢或氟。R.sub.4是氢或氟,R.sub.5是氢、氟或CH.sub.3;或其盐,与药物载体相关联。所施用的量为0.1毫克至400毫克/千克体重,剂量单位形式和剂量量披露。